Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses – IVY Network, September 1, 2022-March 30, 2023

By sjmartinez • November 14, 2024

Lewis NM, Harker EJ, Leis A, Zhu Y, Talbot HK, Grijalva CG, Halasa N, Chappell JD, Johnson CA, Rice TW, Casey JD, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, DeCuir J, Surie D, Dawood FS, Ellington S, Self WH, Martin ET. Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023. Vaccine. 2024 Nov 7;43(Pt 2):126492. doi: 10.1016/j.vaccine.2024.126492. Epub ahead of print. PMID: 39515195.

Tags: bias, covid-19, Estimation, Influenza, Publications, Pulmonary, Critical Care & Sleep Medicine, RSV, vaccine effectiveness

Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Median Survival Among Patients Hospitalized[...]

Adult congenital cardiac interventional training, competencies, and organization. A Statement of the ESC ACHD Working Group, the EAPCI, the AEPC, and the PICS-Society

Chessa M, Brida M, Budts W, Chieffo A, Dua J, Kaleschke G, Kempny A, Kenny D, Krasemann T, Rahbek Schmidt M, Aboulhosn J. Adult congenital[...]

Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for[...]